The Effect of Maximum Tumor Diameter by MRI on Disease Control in Intermediate and High-risk Prostate Cancer Patients Treated With Brachytherapy Boost-Reference-Cited by-同舟云学术

The Effect of Maximum Tumor Diameter by MRI on Disease Control in Intermediate and High-risk Prostate Cancer Patients Treated With Brachytherapy Boost

Published:2022-02 Issue:1 Volume:20 Page:e68-e74
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Parsons Matthew W.,Hutten Ryan J.,Tward Alexander,Khouri Ashley,Peterson John,Morrell Glen,Lloyd Shane,Cannon Donald M.,Johnson Skyler B.

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference21 articles.

1. Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate Cancer

2. Long-term outcomes after treatment with brachytherapy and supplemental conformal radiation for prostate cancer patients having intermediate and high-risk features;Dattoli;Cancer,2007

3. Combination external beam radiation and brachytherapy boost with androgen deprivation for treatment of intermediate-risk prostate cancer: long-term results of CALGB 99809;Hurwitz;Cancer,2011

4. Direct 2-arm comparison shows benefit of high-dose-rate brachytherapy boost vs external beam radiation therapy alone for prostate cancer;Khor;Int J Radiat Oncol Biol Phys,2013

5. Long-term prognostic significance of rising PSA levels following radiotherapy for localized prostate cancer - focus on overall survival;Freiberger;Radiat Oncol,2017

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Brachytherapy based microboosting to the dominant intraprostatic lesion in prostate cancer: A systematic review on treatment outcomes and toxicities;Brachytherapy;2024-09

2. Traditional Prostate Cancer Risk Assessment Scales Do Not Predict Outcomes from Brain Metastases: A Population-Based Predictive Nomogram;Cancers;2024-08-30

3. Multiparametric MRI as a Predictor of PSA Response in Patients Undergoing Stereotactic Body Radiation (SBRT) Therapy for Prostate Cancer;Advances in Radiation Oncology;2023-11

4. The Clinical Significance of Maximum Tumor Diameter on MRI in Men Undergoing Radical Prostatectomy or Definitive Radiotherapy for Locoregional Prostate Cancer;Clinical Genitourinary Cancer;2022-12

5. Findings on Diagnostic Magnetic Resonance Imaging Before Radiotherapy for Prostate Cancer;Canadian Association of Radiologists Journal;2022-11-03